Characterizing Antibiotic-Resistant Bacteria in Urban Wastewater Systems
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of the Study
- 1.3Statement of the Problem
- 1.4Aim and Objectives of the Study
- 1.5Research Questions
- 1.6Research Hypotheses
- 1.7Significance of the Study
- 1.8Scope and Delimitation of the Study
- 1.9Limitations of the Study
- 1.10Organisation of the Study
- 1.11Operational Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Conceptual Review: Antibiotic Resistance in Wastewater Environments
- 2.2Conceptual Review: Urban Wastewater Systems and Microbial Ecology
- 2.3Conceptual Review: Horizontal Gene Transfer in Built-Environment Microbiomes
- 2.4Conceptual Review: Antibiotic Use and Selection Pressure in Municipalities
- 2.5Theoretical Framework: World-Systems Theory as Applied to Urban Health Infrastructures
- 2.6Theoretical Framework: One Health Approach in Environmental AMR Transmission
- 2.7Theoretical Framework: Ecological Niche Theory and Microbial Community Dynamics
- 2.8Empirical Review: Surveillance of AMR in Wastewater: Global Case Studies
- 2.9Empirical Review: Metagenomic Profiling of Wastewater Microbiota
- 2.10Empirical Review: Culture-Based Detection of Clinically Relevant ARGs in Sewage
- 2.11Empirical Review: Treatment Plant Efficacy and Residual ARGs
- 2.12Identified Gaps in the Literature
- 2.13Conceptual Model or Summary of the Review
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design: Empirical Field Study of Urban Wastewater Microbiomes
- 3.2Philosophical Paradigm: Pragmatism in Environmental Microbiology Research
- 3.3Population of the Study: Urban Wastewater Assets and Microbial Communities
- 3.4Sample Size and Sampling Technique: Stratified Sampling of Wastewater Sites
- 3.5Sources and Instruments of Data Collection: Field Sampling, Culture, and Sequencing Protocols
- 3.6Validity and Reliability of Instruments: QA/QC for Microbiological Assays
- 3.7Ethical Considerations: Environmental Health and Biosafety Compliance
- 3.8Data Management and Storage Procedures
- 3.9Data Analysis Plan: Multivariate and Spatial Analyses of AMR Profiles
- 3.10Model Specification or Analytical Framework: ARG Abundances and Community Structure
- 3.11Quality Assurance of Field Data
- 3.12Limitations and Delimitations of Methodology
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- ANALYSIS AND DISCUSSION
- 4.1Data Presentation: Overview of Sampling Sites and Timelines
- 4.2Descriptive Analysis: Microbial Community Composition Across Sites
- 4.3Descriptive Analysis: ARG Prevalence and Diversity Metrics
- 4.4Hypotheses Testing: Spatial Variation in ARG Abundance
- 4.5Hypotheses Testing: Association Between Environmental Variables and AMR Profiles
- 4.6Interpretation of Results: Taxonomic Shifts and Resistance Gene Dissemination
- 4.7Discussion: Comparison with Prior Empirical Studies
- 4.8Discussion: Implications for Urban Water Management and Public Health
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Findings
- 5.2Conclusion
- 5.3Contribution to Knowledge: Advancing AMR Surveillance in Urban Wastewater
- 5.4Practical Recommendations for Municipal Water Authorities
- 5.5Policy Implications and Public Health Considerations
- 5.6Suggestions for Further Studies
Thesis Abstract
Urban wastewater systems represent a critical nexus for the amplification and dissemination of antibiotic-resistant bacteria (ARB) and resistance genes, posing risks to public health through environmental exposure and horizontal gene transfer. This study investigates the prevalence, diversity, and drivers of ARB in municipal wastewater streams to inform mitigation strategies and policy interventions. The aim is to characterize (i) the spatial and temporal patterns of ARB distribution across influent, primary, secondary effluent, and reclaimed water within a large metropolitan wastewater network; (ii) the resistome and associated mobile genetic elements by metagenomic profiling; and (iii) the environmental and operational factors that correlate with ARB abundance and resistance gene loads. Specific objectives include quantify culturable ARB using selective culture-based methods; determine the prevalence of extended-spectrum beta-lactamase (ESBL) and carbapenemase producers via targeted PCR assays; profile the resistome with shotgun metagenomics and annotate resistance determinants against the Comprehensive Antibiotic Resistance Database (CARD); assess the influence of wastewater parameters (chemical oxygen demand, ammonia, nutrient load, temperature, pH) and treatment stage on ARB and resistance gene abundance using multivariate modeling; identify co-occurrence networks between ARB taxa and resistance genes; and compare ARB and resistome signatures with downstream receiving waters to evaluate potential environmental dissemination. A mixed-methods, longitudinal field study will be conducted over 12 months in three sentinel wastewater treatment facilities serving a combined population of about 2.5 million residents. The population of interest comprises bacteria within municipal influent and effluent streams, framed as a dynamic environmental reservoir of antimicrobial resistance. A stratified sampling approach will collect quarterly composite samples from influent, primary effluent, secondary effluent, and tertiary/disinfected discharges, totaling 48 samples per site (144 samples overall). Culture-based assays will enumerate aerobic and facultative anaerobic ARB on selective media (e.g., MacConkey agar with cefotaxime, ceftazidime, and meropenem), followed by species identification via MALDI-TOF MS and confirmation of resistance phenotypes through disk diffusion according to CLSI guidelines. PCR screening will detect key resistance determinants (blaCTX-M, blaKPC, blaNDM, blaOXA-48-like) and integron-associated genes (class 1 and 2). Shotgun metagenomic sequencing will be performed on a subset of samples (n=24 per site) to characterize the resistome and mobilome, with bioinformatic analysis conducted against CARD, ResFinder, and mobile genetic element databases. Physicochemical parameters (COD, BOD, ammonia, nitrate, phosphate, turbidity, temperature, pH) and operational data ( Hydraulic Retention Time, sludge age, disinfection efficacy) will be collected in parallel. Data analysis will employ descriptive statistics for ARB abundance, multivariate generalized linear models to identify predictors of ARB counts and resistance gene abundance, and redundancy analysis to relate microbial community structure to environmental variables. Network analysis will elucidate co-occurrence patterns between taxa and resistance determinants. A theoretical framework incorporating the One Health concept and the Resistance Selection Pressure model will anchor interpretation, complemented by the ecological risk assessment approach to quantify potential human and environmental exposure. Expected findings include higher ARB concentrations and resistome complexity in influent and variable reductions across treatment stages, with residual ARB and genes detected in secondary and tertiary effluents, and detectable signatures in downstream waters. The study anticipates identifying critical factors driving ARB persistence, such as high organic load, suboptimal disinfection, and horizontal gene transfer potential via integrons. The contribution to knowledge lies in providing a comprehensive, lifecycle-based assessment of ARB and resistome dynamics within urban wastewater systems, evidencing links between treatment performance and antimicrobial resistance dissemination, and offering data-driven recommendations for process optimization, monitoring frameworks, and policy strategies to mitigate environmental and public health risks. The main conclusion will emphasize the necessity of integrated wastewater management to curtail resistance spread, with recommendations including enhanced disinfection protocols, routine resistome monitoring, and targeted interventions at the influent stage to reduce ARB load entering treatment plants.
Thesis Overview
This research investigates the presence and character of antibiotic-resistant bacteria (ARB) in urban wastewater systems, focusing on how these organisms emerge, persist, and may be transferred through treatment stages and into the environment. It matters because wastewater is a nexus where antibiotic resistance genes and resistant bacteria from hospitals, households, and industry can mix, potentially undermining public health and complicating infection control. The study addresses gaps in how ARB diversity, resistance mechanisms, and potential exposure risks are defined across different urban wastewater stages, and it seeks to link environmental data with clinical relevance to better inform risk management.
What the researcher will do step by step
1. Define the study sites and scope: select three to five urban wastewater networks representing varied treatment configurations and catchment characteristics.
2. Collect samples systematically: obtain influent, primary and secondary treated effluent, and sludge at regular intervals over 12 months to capture temporal and seasonal variation.
3. Detect and quantify ARB: culture-based methods paired with molecular approaches to identify key bacterial groups and quantify resistance prevalence, using selective media and qPCR targeting common resistance genes (e.g., blaCTX-M, mecA, vanA).
4. Characterize resistance mechanisms: perform whole-genome sequencing on representative isolates to uncover resistance determinants, mobile genetic elements, and phylogenetic relationships.
5. Assess treatment efficacy: compare ARB abundance and resistance gene loads across treatment stages to evaluate removal efficiency and factors influencing persistence.
6. Analyze data: apply descriptive statistics, regression analyses to identify associations between physicochemical parameters (e.g., antibiotic concentrations, turbidity) and ARB levels, and multivariate methods to explore patterns across sites.
7. Interpret findings in context: contrast environmental ARB profiles with available clinical resistance data to assess potential public health implications.
8. Report uncertainties and limitations: discuss sampling constraints, detection limits, and generalizability.
Expected contribution and outcome
- A comprehensive, empirically grounded picture of ARB prevalence and resistance gene distribution in urban wastewater systems, including seasonal and process-stage variations.
- Insights into the effectiveness of common wastewater treatments in reducing ARB and resistance gene loads, informing policy and treatment optimization.
- A framework for risk assessment of ARB release, guidance for monitoring programs, and a baseline for future longitudinal and comparative studies.
In sum, the study aims to bridge environmental microbiology and public health by detailing how ARB persist and move through urban wastewater, enabling better mitigation and surveillance strategies.